Category:

BIOTECHNOLOGY

NSF TraQtion Powers Novozymes’ Raw Material Management in Industry First

NSF TraQtion is a cloud-based quality and compliance software that provides organizations with a comprehensive platform to proactively manage their supply chain, sites, and product quality.

Vigilant Biosciences Debuts the Revolutionary BeVigilant OraFusion System in the UK

The BeVigilant OraFusion System stands out as an innovative device in the oral cancer domain, serving as a critical tool in oral cancer detection by identifying specific salivary biomarkers and integrating intelligent software to evaluate clinical risk factors.

Alloy Therapeutics and Wheeler Bio Announce Preferred Service Offering for Alloy Partners to Accelerate the Translation from Discovery to CMC

Alloy Therapeutics and Wheeler Bio are offering a premium service experience for existing and future ATX-Gx platform users and Alloy Discovery Service partners who also contract Portable CMC™ development services with Wheeler Bio

Ginkgo Bioworks and XWELL Implement Expanded CDC Traveler-based Genomic Surveillance Program to Test for More than 30 Known Pathogens

"By building sustainable, scalable infrastructure that is capable of detecting biological threats beyond SARS-CoV-2, the TGS program is a global leader in the evolution of biosecurity," said Matt McKnight, General Manager for Biosecurity at Ginkgo Bioworks. "Persistent monitoring can give officials an early warning by offering a view into how pathogens spread across the globe."

The Role of Biomedical Waste Management in Preventing Disease Outbreaks

As we delve into the intricate world of biomedical waste, we'll uncover its significance in preventing disease outbreaks, especially in places like Houston, a city that thrives on medical advancements.

Oxford Nanopore Technologies and Fabric Genomics Collaborate to Launch an Integrated Whole-Genome Sequencing Solution to Advance the Future of Paediatric Patient Care

"For this incredibly high-risk patient population, speed and data-rich insights matter,” said Gordon Sanghera, PhD, CEO of Oxford Nanopore Technologies. “We are excited to team up with Fabric Genomics to develop an end-to-end analysis tool for the clinical reporting of nanopore sequencing data in paediatric care settings that will make it easier for healthcare providers to leverage genetic insights and, in the future, support the health and wellbeing of children and families.”

Frontier Bio Leads Medical Innovation with “Lab-Grown” Blood Vessel Technology for Replacing Animal Testing

By introducing lab-grown vessels, Frontier Bio is championing a future where reliance on such animal testing is significantly reduced, if not eliminated.

Mindray Expands Its Cardiac Biomarker Portfolio with Cutting-Edge hs-cTnI and NT-proBNP Assays, Empowering Enhanced Cardiovascular Diseases Care

The two assays are the collaborative effort of Mindray and HyTest, a Mindray company and a prominent global provider of antibodies and antigens. HyTest, renowned for its cardiac biomarker expertise, had its cardiac troponin complex material selected as the international troponin standard by AACC in 2004.

SOPHiA GENETICS Enters New Collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca to Address Global Inequalities in Comprehensive Cancer Care

SOPHIA GENETICS notes the three companies will collaborate to improve global access to advanced cancer testing and data, broadening access to cutting-edge science.
spot_img
spot_img